Ambien CR (zolpidem) — Blue Cross Blue Shield of New Mexico
insomnia (quantity limit criteria)
Initial criteria
- Quantity limit for the Target Agent(s) will be approved when ONE of the following is met:
- 1. The requested quantity (dose) does NOT exceed the program quantity limit OR
- 2. The requested quantity (dose) exceeds the program quantity limit AND BOTH of the following:
- A. ONE of the following:
- 1. BOTH of the following:
- A. The requested agent does NOT have a maximum FDA labeled dose for the requested indication AND
- B. There is support for therapy with a higher dose for the requested indication OR
- 2. BOTH of the following:
- A. The requested quantity (dose) does NOT exceed the maximum FDA labeled dose for the requested indication AND
- B. There is support for why the requested quantity (dose) cannot be achieved with a lower quantity of a higher strength that does NOT exceed the program quantity limit OR
- 3. BOTH of the following:
- A. The requested quantity (dose) exceeds the maximum FDA labeled dose for the requested indication AND
- B. There is support for therapy with a higher dose for the requested indication AND
- B. ONE of the following:
- 1. The patient is using one insomnia agent OR
- 2. BOTH of the following:
- A. The patient is using TWO insomnia agents AND
- B. The previous insomnia agent will be discontinued and replaced by the requested agent
Approval duration
12 months